JLJohn R. Leyendecker

John R. Leyendecker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John R. Leyendecker has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MRI of Pregnancy-Related Issues: Abnormal Placentation

    by John R. Leyendecker, Melinda DuBose, Keyanoosh Hosseinzadeh, Ryan Stone, John Gianini, David D. Childs, Anthony N. Snow, Heather Mertz

    OBJECTIVE. In this article, we review the clinical significance of abnormal placentation and the role of MRI in diagnosis and management of this potentially morbid condition. We present our clinical perspective on diagnosing this challenging problem with MRI and review the imaging findings that can lead to a correct diagnosis. CONCLUSION. As abnormal placentation becomes more prevalent, in large part due to the markedly rising rates of cesarean delivery, there is a need for accurate antenatal diagnosis of this condition to prevent maternal morbidity and mortality. Maternal and fetal outcomes can be optimized through multidisciplinary planning to achieve accurate diagnosis and anticipation of the extent of abnormal placentation in the antenatal period. Imaging findings of abnormal placentation have been described for both ultrasound and MRI, although limitations exist for each technique. Although ultrasound remains the primary screening modality for the detection of abnormal placentation, MRI is a compleme...


  • MR Enterography in the Management of Patients with Crohn Disease

    by John R. Leyendecker, Richard S. Bloomfeld, David J. DiSantis, Gregory S. Waters, Ryan Mott, Robert E. Bechtold

    Crohn disease is a complex pathologic process with an unpredictable lifelong course that includes frequent relapses. It often affects young patients, who are most vulnerable to the potential adverse effects of repeated exposure to ionizing radiation from computed tomography performed for diagnosis and surgical planning. The small intestine is the bowel segment that is most frequently affected, but it is the least accessible with endoscopic techniques. Magnetic resonance (MR) enterography has the potential to safely and noninvasively meet the imaging needs of patients with Crohn disease without exposing them to ionizing radiation. Appropriate use of MR enterography requires a carefully crafted protocol to depict signs of active inflammation as well as complications such as bowel obstruction, fistulas, and abscesses. Interpretation of MR enterographic images requires familiarity with the imaging signs and mimics of active bowel inflammation and stenosis. Although MR enterography currently is helpful for management in individual patients, the standardization of acquisition protocols and interpretive methods would increase its usefulness for more rigorous, systematic assessments of Crohn disease treatment regimens.


  • Magnetic resonance urography

    by John R. Leyendecker, John W. Gianini

    Excellent contrast resolution and lack of ionizing radiation make magnetic resonance urography (MRU) a promising technique for noninvasively evaluating the entire urinary tract. While MRU currently lags behind CT urography (CTU) in spatial resolution and efficiency, new hardware and sequence developments have contributed to a resurgence of interest in MRU techniques. By combining unenhanced sequences with multiphase contrast-enhanced and excretory phase imaging, a comprehensive assessment of the kidneys, ureters, bladder, and surrounding structures is possible with image quality rivaling that obtained with other techniques. At the same time, formidable challenges remain to be overcome and further clinical validation is necessary before MRU can replace other forms of urography. In this article, we demonstrate the current potential of MRU to demonstrate a spectrum of urologic pathology involving the kidneys, ureters, and bladder while discussing the limitations and current status of this evolving technique.


  • Fat-Suppressed Dynamic and Delayed Gadolinium-Enhanced Volumetric Interpolated Breath-hold Magnetic Resonance Imaging of Cholangiocarcinoma

    by John R. Leyendecker, Mandip Gakhal, Khaled M. Elsayes, Ronan McDermott, Vamsidhar R. Narra, Jeffrey J. Brown

    To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92%, 67%, 75%, and 21%; isointense in 8%, 8%, 17%, and 12%; and hyperintense in 0%, 25%, 8%, and 67% of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25% of patients and the lowest in 33%. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75% of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38% of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.


  • Complete Pancreatic Encasement of the Portal Vein (Circumportal Pancreas)

    by John R. Leyendecker, Scott G. Baginski

    Computed tomography and magnetic resonance imaging findings in 4 patients with complete pancreatic encasement of the portal vein are presented, with emphasis on the use of multiplanar reconstructions in demonstrating this anomaly.


  • MR Urography: Techniques and Clinical Applications

    by John R. Leyendecker, Craig E. Barnes, Ronald J. Zagoria

    Magnetic resonance (MR) urography comprises an evolving group of techniques with the potential for allowing optimal noninvasive evaluation of many abnormalities of the urinary tract. MR urography is clinically useful in the evaluation of suspected urinary tract obstruction, hematuria, and congenital anomalies, as well as surgically altered anatomy, and can be particularly beneficial in pediatric or pregnant patients or when ionizing radiation is to be avoided. The most common MR urographic techniques for displaying the urinary tract can be divided into two categories: static-fluid MR urography and excretory MR urography. Static-fluid MR urography makes use of heavily T2-weighted sequences to image the urinary tract as a static collection of fluid, can be repeated sequentially (cine MR urography) to better demonstrate the ureters in their entirety and to confirm the presence of fixed stenoses, and is most successful in patients with dilated or obstructed collecting systems. Excretory MR urography is performed during the excretory phase of enhancement after the intravenous administration of gadolinium-based contrast material; thus, the patient must have sufficient renal function to allow the excretion and even distribution of the contrast material. Diuretic administration is an important adjunct to excretory MR urography, which can better demonstrate nondilated systems. Static-fluid and excretory MR urography can be combined with conventional MR imaging for comprehensive evaluation of the urinary tract. The successful interpretation of MR urographic examinations requires familiarity with the many pitfalls and artifacts that can be encountered with these techniques.


  • Kidneys and MR Urography

    by John R. Leyendecker, David D. Childs


  • MR Imaging of Maternal Diseases of the Abdomen and Pelvis during Pregnancy and the Immediate Postpartum Period

    by John R. Leyendecker, Vladislav Gorengaut, Jeffrey J. Brown

    Magnetic resonance (MR) imaging provides multiplanar large field-of-view images of the body with excellent soft-tissue contrast and without ionizing radiation. As a result, MR imaging is increasingly being used to image the maternal abdomen and pelvis during and immediately after pregnancy. Results of rapid T1- and T2-weighted imaging are often diagnostic, and blood vessels, ductal structures, and the urinary tract can frequently be visualized without intravenous administration of contrast material. Until more conclusive safety data become available, MR imaging should be reserved for cases in which results of ultrasonography are inconclusive and patient care depends on further imaging. In the setting of acute abdomen during pregnancy, MR imaging allows identification of areas of inflammation, abscess formation, hemorrhage, and bowel obstruction. MR imaging also helps determine the organ of origin, extent, and composition of maternal neoplasms and is useful in evaluation of müllerian duct anomalies and abnormalities of placental formation, position, and implantation. Many postpartum complications such as retained products of conception and uterine dehiscence may be diagnosed with MR imaging when results of other modalities are indeterminate.